Skip to main content
. 2019 Oct 22;10:1125. doi: 10.3389/fneur.2019.01125

Table 1.

Defining clinical features of the PSP phenotypes based on MDS-PSP criteria.

Clinical domains Certainty level
Level 1 Level 2 Level 3
Ocular motor dysfunction O1 O2 O3
Vertical supranuclear gaze palsy Slow vertical saccades Macro square wave jerks or eyelid opening apraxia
Postural instability P1 P2 P3
Repeated unprovoked falls during the first 3 years of disease Falls on pull-test during the first 3 years of disease Three or more steps backwards on pull-test during the first 3 years of disease
Akinesia A1 A2 A3
Progressive gait freezing during the first 3 years of disease Levodopa resistant bradykinesia with axial-dominant rigidity Parkinsonism (bradykinesia and rigidity) with or without: tremor/asymmetry/levodopa response
Cognitive dysfunction C1 C2 C3
Speech/language disorders Frontal cognitive/behavioral presentation Corticobasal syndrome